A drug normally used to prevent tissue rejection following organ transplants could be repurposed to help treat human metapneumovirus (HMPV) infection in children.
A class of metal-based compounds acts as a shield to protect cells from viruses new research has found.
Repurposed medications may guide future strategies for COVID-19 treatment.
A new scientific discovery, thanks to one of the research groups at Griffith University’s Institute for Glycomics, is providing new...
Griffith’s Institute for Glycomics have made a promising discovery in the treatment and prevention of human parainfluenza virus.
Four teams of expert scientists from Griffith University’s Institute for Glycomics are targeting the virus SARS-CoV-2 to discover new vaccines...
